News

RenovoRx Announces Sixth U.S. Patent

TIGeR-PaC — a Phase III Clinical Trial Continues Enrolling Pancreatic Cancer Patients in the U.S. and Europe Los Altos, CA, June 9, 2020 – RenovoRx, an innovator in targeted cancer…
Read More

* Individual results may vary.

Menu